Spectrum Pharmaceuticals Announces Publication in the Journal of Clinical … – Business Wire (press release)
Spectrum Pharmaceuticals Announces Publication in the Journal of Clinical …Business Wire (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on t…
